How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?

Nadine Norton, Edith A. Perez

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

Clinical outcome of patients with breast cancer is based on patient and tumor-related factors. The relevant tumor-related factors include anatomical extent and biology. Of the prognostic and predictive biological markers available, hormone receptors (defined as estrogen and progesterone receptors) and HER2 receptors, have been independently validated. Pertinent questions to be addressed include their combined impact on prognosis, their relevance in terms of sites of metastases, and whether they change in primary versus recurrent tumors. Although these questions are being addressed in clinical trials, epidemiological results, such as those derived from the National Comprehensive Cancer Network dataset, add perspective to our understanding of these two most relevant biological prognostic/predictive markers.

Original languageEnglish (US)
Article number101
JournalBreast Cancer Research
Volume15
Issue number1
DOIs
StatePublished - Jan 14 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?'. Together they form a unique fingerprint.

  • Cite this